SCHEMBL7797358

SCHEMBL7797358

COc1ccc(-c2ccc(-c3ccsc3Cc3ccccc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 6/20 0.60
LTA4H P09960 2/20 0.53
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MAPK1 P28482 1/20 0.43
CETP P11597 1/20 0.43
PTGS2 P35354 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ABL1 P00519 1/20 0.41
ABCB1 P08183 1/20 0.41
BCR P11274 1/20 0.41
BACE1 P56817 1/20 0.41
HTT P42858 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
MITF O75030 1/20 0.40
RAB9A P51151 1/20 0.40
LMNA P02545 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5551078 0.77 LTA4H (0.88) LTA4HSMN1; SMN2MEN1KMT2AHTT
SCHEMBL11819224 0.73 LTA4H (0.80) LTA4HALDH1A1SMN1; SMN2KMT2AABL1
SCHEMBL5146089 0.73 PTGS2 (0.47) PTPN1ALDH1A1SMN1; SMN2PTGS2ABL1
SCHEMBL15055602 0.73 KEAP1 (0.56) PTPN1LTA4HALDH1A1MEN1KMT2A
SCHEMBL570480 0.71 LTA4H (1.00) LTA4HMEN1KMT2AHTTNPC1
SCHEMBL11521644 0.70 LTA4H (0.51) PTPN1LTA4HALDH1A1SMN1; SMN2MAPK1
SCHEMBL19360431 0.69 LTA4H (0.71) LTA4HALDH1A1SMN1; SMN2KMT2AHTT
SCHEMBL22451382 0.69 LTA4H (0.71) LTA4HALDH1A1SMN1; SMN2LMNA
SCHEMBL6059611 0.69 LTA4H (0.71) LTA4HALDH1A1SMN1; SMN2LMNA
SCHEMBL25986535 0.69 LTA4H (0.71) LTA4HALDH1A1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010053785-A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia WYETH 2001-12-20 US disclosed
US-20010041715-A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia AMERICAN HOME PRODUCTS 2001-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010053785-A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia GPR119, INSR, IAPP PTPN1 1004/4885LTA4H 3838/4885ALDH1A1 350/4885
US-20010041715-A1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia GPR119, INSR, IAPP PTPN1 1004/4885LTA4H 3838/4885ALDH1A1 350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.